Data / Form D filings / Virpax Pharmaceuticals, Inc.
Virpax Pharmaceuticals, Inc.: Form D filings
Virpax Pharmaceuticals, Inc., a pharmaceuticals company in Berwyn, PA, filed 2 Form D notices with the SEC between 2018 and 2024. The latest, on July 12, 2024, reports $2.5 million sold of a $2.5 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1055 WESTLAKES DRIVE, SUITE 300, Berwyn, PA, 19312
- Phone
- (610) 727-4597
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1708331
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 12, 2024 | New notice | $2,500,000 | $2,500,000 | 1 | Jul 5, 2024 | sec.gov | |
| Apr 5, 2018 | New notice | $3,000,000 | $1,379,000 | $1,621,000 | 8 | Feb 8, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Vanila M. Singh | Director | |
| Gerald Bruce | Executive Officer, Director | |
| Gary M. Herman | Director | |
| Vinay Shah | Executive Officer | |
| Katharyn M. Field | Director | |
| Judy M. Su | Director | |
| Sheila M. Mathias | Executive Officer | |
| Eric Floyd | Director | |
| Jatinder M. Dhaliwal | Director |
Other pharmaceuticals companies in Pennsylvania that filed recently
- Telemachus Therapeutics, Inc. $375,000 · Oct 28, 2026
- EpiVario Inc. $185,000 · Oct 13, 2026
- Maxona Pharmaceuticals, Inc. $5.8 million · Aug 14, 2026
- PLEOPHARMA, INC. $5.5 million · Aug 10, 2026
- Duo Oncology Inc. $1.6 million · Aug 7, 2026
Every Form D from the week of Jul 8, 2024 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Virpax Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.